Researchers studied new therapies for Type II diabetes, aiming for higher efficacy, fewer side effects, and lower costs. This is important for improving patient outcomes and easing strain on healthcare systems globally.
Scientists analyzed the chemical compounds in different parts of pumpkins and found they can help manage diabetes by inhibiting carbohydrase enzymes and promoting glucose uptake. Pumpkin is a potential functional food for diabetes management.
Study finds germination and cooking boost red kidney beans' antidiabetic properties, potentially aiding in diabetes management as a functional food.
Clitoria ternatea extract shows potential for treating diabetes-induced cognitive impairment. Cobalt oxide nanoparticles may improve brain drug delivery, but high doses are neurotoxic. Low doses show neuroprotective effects, warranting further study.
NS (black cumin) shows promise in reducing inflammation and oxidative stress associated with diabetic neuropathy. Research suggests potential benefits for treating complications of diabetes with fewer side effects.
Extracts from okra, mulberry, and pomegranate leaves and peel help diabetic rats by reducing blood glucose, inflammation, and restoring brain health. Promising for treating diabetic neuropathy.
Pomegranate seed oil self-nanoemulsifying system has potent antioxidant, anti-diabetic, and anti-lipase activities. Potential for oral medications in oxidative stress, diabetes, and obesity treatment.Enhanced drug formulations in terms of pharmacokinetics and pharmacodynamics.
Researchers isolated neochlorogenic acid from Houttuynia cordata Thunb., showing potential as a natural α-glucosidase inhibitor to lower blood glucose levels. This study lays the groundwork for developing new hypoglycemic treatments.